Trial Profile
Study of Chidamide Plus DICE Regimen for Patients With Relapse or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2022
Price :
$35
*
At a glance
- Drugs Tucidinostat (Primary) ; Cisplatin; Dexamethasone; Etoposide; Ifosfamide
- Indications B-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 12 Apr 2017 New trial record